Toxoplasma gondii at the Host Interface: Immune Modulation and Translational Strategies for Infection Control
Vaccines · 31.07.2025 · 13 (8) · 819
DOI: 10.3390/vaccines13080819 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 31.07.2025. Verfasst von Billy J Erazo Flores und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI 53706, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIGMS NIH HHS, NIAID NIH HHS.
Themen: Nosokomiale Infektionen
Abstract (Originalsprache)
Toxoplasma gondii is an intracellular protozoan found worldwide that is capable of infecting nearly all warm-blooded animals, including humans. Its parasitic success lies in its capacity to create chronic infections while avoiding immune detection, altering host immune responses, and disrupting programmed cell death pathways. This review examines the complex relationship between T. gondii and host immunity, focusing on how the parasite influences innate and adaptive immune responses to survive in immune-privileged tissues. We present recent findings on the immune modulation specific to various parasite strains, the immunopathology caused by imbalanced inflammation, and how the parasite undermines host cell death mechanisms such as apoptosis, necroptosis, and pyroptosis. These immune evasion tactics enable prolonged intracellular survival and pose significant challenges for treatment and vaccine development. We also review advancements in therapeutic strategies, including host-directed approaches, nanoparticle drug delivery, and CRISPR-based technologies, along with progress in vaccine development from subunit and DNA vaccines to live-attenuated candidates. This review emphasizes the importance of T. gondii as a model for chronic infections and points out potential avenues for developing innovative therapies and vaccines aimed at toxoplasmosis and similar intracellular pathogens.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI 53706, USA.
ORCID-Profile: Laura J Knoll
Förderung
- NIH HHS
- NIGMS NIH HHS
- NIAID NIH HHS
- CSRD VA
- National Institutes of Health National Institute of Allergy and Infectious Diseases
- graduate training in cellular and molecular pathogenesis of human diseases T32 fellowship
- parasitology and vector biology training program T32 fellowship
- Robert H. and Carol L. Deibel distinguished graduate fellowship in food safety research
Zitieren
APA
Erazo Flores, B. J., & Knoll, L. J. (2025). Toxoplasma gondii at the Host Interface: Immune Modulation and Translational Strategies for Infection Control. Vaccines, 13(8), 819. https://doi.org/10.3390/vaccines13080819
Vancouver
Erazo Flores BJ, Knoll LJ. Toxoplasma gondii at the Host Interface: Immune Modulation and Translational Strategies for Infection Control. Vaccines. 2025;13(8):819. doi:10.3390/vaccines13080819
BibTeX
@article{ErazoFlores2025,
author = {Erazo Flores, Billy J and Knoll, Laura J},
title = {Toxoplasma gondii at the Host Interface: Immune Modulation and Translational Strategies for Infection Control},
journal = {Vaccines},
year = {2025},
volume = {13},
number = {8},
pages = {819},
doi = {10.3390/vaccines13080819}
}
EUVIMED